Bile biopsy could spot bile duct cancer faster
NCT ID NCT06416397
First seen Jan 09, 2026 · Last updated May 22, 2026 · Updated 18 times
Summary
This study aims to develop a new way to diagnose cholangiocarcinoma (bile duct cancer) by analyzing proteins in bile fluid. Researchers will compare the accuracy of this bile-based test with standard tissue biopsy in 200 adults who have bile duct narrowing. If successful, the approach could offer a less invasive and faster diagnostic option.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOLANGIOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Bordeaux
RECRUITINGPessac, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.